Aclaris Therapeutics Inc (ACRS)

CapEx to Revenue

3.56%

Quarterly · Period ending:

ACRS logo

ACRS CapEx to Revenue

Latest reported3.56%
ACRS Quarterly CapEx/Revenue (0.00% → 3.56%)
High-resolution chart · PNG

ACRS capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aclaris Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
3.5605%
0.6513%
1.8533%
0.6972%
1.1818%
60.2062%
388.7743%
0%
0.5061%
5.6297%
2.51%
0.905%
12.3596%
21.875%
1.3543%
0.7887%
12.1728%
11.287%
13.3245%
3.3755%
2.8509%
0%
0.5063%
20.98%
0.8309%
8.8131%
24.2922%
83.6216%
4.1091%
5.6338%
3.9793%
34.398%
9.5756%
26.6547%
57.7578%
39.4737%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.